Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 6 to 7 amino acid residues in defined sequence
Reexamination Certificate
2011-01-04
2011-01-04
Tsang, Cecilia (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
6 to 7 amino acid residues in defined sequence
Reexamination Certificate
active
07863415
ABSTRACT:
The present invention provides compositions comprising amiloride amino acid and peptide conjugates. Efficient methods are also provided for administering the amiloride conjugates of the present invention for treating cancer or a central nervous system disease or disorder or for preventing or reducing ischemia-reperfusion injury. Further, kits are provided for the treatment of a central nervous system disease or disorder or for the prevention or reduction of ischemia-reperfusion injury using the amiloride conjugates of the present invention.
REFERENCES:
Pato, et al, “Synthesis of macromolecular conjugates of a urokinase inhibitor: amiloride,” Journal of Bioactive and compatible Polymers, (1999), vol. 14(2), 99-121.
Thornber, “Isosterism and Molecular Modification in Drug Design,” Chem Soc. Rev. (1979), vol. 8(4), pp. 563-580.
Tompa P., et al, “On the sequential determinants of calpain cleavage,” J Biol Chem. May 14, 2004;279(20):20775-85.
Bischof, G. et al., “Effect of extracellular pH on intracellular pH-regulation and growth in a human colon carcinoma cell-line,”Biochimia et Biophysics Acta, 1996, vol. 1282, pp. 131-139.
Boyer, M.J. et al., “Regulation of Intracellular pH in Tumor Cell Lines: Influence of Microenvironmental Conditions,”Cancer Research, Aug. 15, 1992, vol. 52, pp. 4441-4447.
Chen, E.I. et al., “A Unique Substrate Recognition Profile for Matrix Metallproteinase-2,”The Journal of Biological Chemistry, Feb. 8, 2002, vol. 277, No. 6, pp. 4485-4491.
Cohen, G.M., “Caspases: the executioners of apoptosis,”Biochem. J., 1997, vol. 326, pp. 1-16.
Cragoe, E.J., JR. et al., “Pyrazine Diuretics. II. N-Amidino-3-amino-5-substituted 6-Halopyrazinecarboxamides,”J. Med. Chem., Jan. 1967, vol. 10, pp. 66-75.
Denault, J-B. et al., “Capases: Keys in the Ignition of Cell Death,”Chemical Reviews, 2002, vol. 102, No. 12, pp. 4489-4499.
Dobson, G.P. et al., “Phosphofructokinase control in muscle: nature and reversal of pH-dependent ATP inhibition,”Am. J. Physiol., 1986, vol. 250, pp. R71-R76.
Frelin, C. et al., “Amiloride and its analogs as tools to inhibit Na+transportviathe Na+channel, the Na+/H+antiport and the Na+/Ca2+ exchanger,”Biochimie, 1988, vol. 70, pp. 1285-1290.
García-Cañero, R. et al., “Na+:H+exchange inhibition induces intracellular acidosis and differentially impairs cell growth and viability of human and rat hepatocarcinoma cells,”Toxicology Letters, 1999, vol. 106, pp. 215-228.
Gennaro, A.R. et al. (eds.),Remington's Pharmaceutical Sciences, 17th Edition, 1985, Mack Publishing Co.: Easton, PA, Table of Contents only, 7 pages.
Ghosh, A.K. et al., “Solid-Phase Synthesis ofN-Acyl-N-Alkyl/Aryl Disubstituted Guanidines,”J. Org. Chem., 2001, vol. 66, No. 6, pp. 2161-2164.
Gorin, F.A. et al., “Novel Analogues of Enkephalin: Identification of Functional Groups Required for Biological Activity,”Journal of Medicinal Chemsitry, 1980, vol. 23, No. 10, pp. 1113-1122.
Gorin. F. et al., “Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft,”Acta Neuropathol, 2004, vol. 107, pp. 235-244.
Gumina, R.J. et al., “Inhibition of the Na+/H+Exchanger Confers Greater Cardioprotection Against 90 Minutes of Myocardial Ischemia Than Ischemic Preconditioning in Dogs,”Circulation, 1999, vol. 100, pp. 2519-2526.
Hasuda, K. et al., “Antitumor Activity of Nigericin and 5-(N-ehtyl-N-isopropyl)amiloride: An Approach to Therapy Based on Cellular Acidification and the Inhibition of Regulation of Intracellular pH,”Oncology Research, 1994, vol. 6, No. 6, pp. 259-268.
Hegde, M. et al., “Amiloride Kills Malignant Giloma Cells Independent of Its Inhibition of the Sodium-Hydrogen Exchanger,”The Journal of Pharmacology and Experimental Therapeutics, 2004, vol. 310, No. 1, pp. 67-74.
Henkel, B. et al., “Investigation on Solid-Phase Peptide Synthesis in N-to-C Direction (inverse Synthesis),”Liebigs Ann. Recueil, 1997, pp. 2161-2168.
Horvat, B. et al., “Tumour Cell Proliferation is Abolished by Inhibitors of Na+/H+and HCO−3/CI−Exchange,”Eur. J. Cancer, 1993, vol. 29A, No. 1, pp. 132-137.
Klein, H.H. et al., “Myocardial Protection by Na30-H+Exchange Inhibition is Ischemic, Reperfused Porcine Hearts,”Circulation, Aug. 15, 1995, vol. 92, No. 4, pp. 912-917.
Lah, T.T. et al., “Clinical and experimental studies of cysteine cathepsins and their inhibitors in human brain tumors,”The International Journal of Biological Markers, 2000, vol. 15, , No. 1, pp. 90-93.
L'Allemain, G. et al., “Blockage of the Na30/H+Antiport Abolishes Growth Factor-induced DNA Synthesis in Fibroblasts,”The Journal of Biological Chemistry, Apr. 10, 1984, vol. 259, No. 7, pp. 4313-4319.
Levic{hacek over (a)}r, N. et al., “Proteases in brain tumour progession,”Acta Neurochir, 2003, vol. 145, pp. 825-838.
Marshall, G.R., “Peptide Interactions with G-Protein Coupled Receptors,”Biopolymers, 2001, vol. 60, pp. 246-277.
Masereel, B. et al., “An overview of inhibitors of Na30/H+exchanger,”European Journal of Medicinal Chemistry, 2003, vol. 38, pp. 547-554.
Miller, S.M. et al., “Comparison of the Proteolytic Susceptibilites of Homologous L-Amino Acid, D-Amino Acid, and N-Substituted Glycine Peptide and Peptoid Oligomers,”Drug Development Research, 1995, vol. 25, pp. 20-32.
Molineaus, C.J. et al., “An inhibitor of Endopeptidase-24.15 Blocks the Degradation of Intraventricularly Administered Dynorphins,”Journal of Neurochemistry, 1990, vol. 55, No. 2, pp. 611-618.
Musgrove, E. et al., “Relationship between Cytoplasmic pH and Proliferation during Exponential Growth and Cellular Quiescence,”Experimental Cell Research., 1987, vol. 172, pp. 65-75.
Numata, M. et al., “Molecular Cloning and Characterization of a Novel (Na+,K+)/H+Exchanger Localized to thetrans-Golgi Network,”The Journal of Biological Chemistry, May 18, 2001, vol. 276, No. 20, pp. 17387-17394.
Orlowski, J. et al., “Na+/H+Exchanges of Mammalian Cells,”The Journal of Biological Chemistry, Sep. 5, 1997, vol. 272, No. 36, pp. 22373-22376.
Palandoken, H. et al., “Amiloride Peptide Conjugates: Prodrugs for Sodium-Proton Exchange Inhibition,”The Journal of Pharmacology and Experimental Therapeutics, 2004, vol. 312, No. 3, pp. 961-967.
Piper, H.M. et al., “The role of Na+/H+exchange in ischemia-reperfusion,”Basic Res. Cardiol, 1996, vol. 91, No. 3, pp. 191-202.
Roques, B.P. et al., “Neutral Endopeptidase 24.11: Structure, Inhibition, and Experimental and Clinical Pharmacology,”Pharmacological Reviews, 1993, vol. 45, No. 1, pp. 87-146.
Sasaki, T. et al., “Comparative Specificity and Kinetic Studies on Porcine Calpain I and Calpain II with Naturally Occurring Peptides and Synthetic Fluorogenic Substrates,”The Journal of Biological Chemistry, Oct. 25, 1984, vol. 259, No. 20, pp. 12489-12494.
Satoh, J. et al., “Importance of Ca2+ influx by Na+/Ca2+exchange under normal and sodium-loaded conditions in mammalian ventricles,”Molecular and Cellular Biochemistry, 2003, vol. 242, pp. 11-17.
Scholz, W. et al., “Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion,”Cardiovascular Research, 1995, vol. 29, pp. 260-268.
Suzuki, Y. et al., “SM-20220, a Na+/H+exchanger inhibitor: effects on ischemic brain damage through edema and neutrophil accumulation in a rat middle cerebral artery occlusion model,”Brain Research, 2002, vol. 945, pp. 242-248.
Szolgay-Daniel, E. et al., “Effects of Amiloride Treatment on U-118 MG Human Glioma and HT-29 Human colon Carcinoma Cells,”Cancer Research, Feb. 1, 1991, vol. 51, pp. 1039-1044.
Tardif, J-C et al., “
Gorin Fredric A.
Nantz Michael H.
Heard Thomas S
The Regents of the University of California
Townsend and Townsend / and Crew LLP
Tsang Cecilia
LandOfFree
Amino acid and peptide conjugates of amiloride and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid and peptide conjugates of amiloride and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid and peptide conjugates of amiloride and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2634295